Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07661342
PHASE3

DEPART Study at Yale

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

This is a randomized study to determine whether radiation therapy reduces the risk of progression / recurrence of Dupuytren's disease / contracture.

Official title: Dupuytren's Disease Evaluation of Preventative or Adjuvant Radiation Therapy: DEPART

Key Details

Gender

All

Age Range

30 Years - Any

Study Type

INTERVENTIONAL

Enrollment

158

Start Date

2026-08-01

Completion Date

2028-12-30

Last Updated

2026-06-22

Healthy Volunteers

No

Interventions

RADIATION

Radiation Therapy

Radiation therapy (RT) should commence within 12 weeks of randomization in the prevention group and within 12 weeks of local treatment (NA) for the adjuvant group. RT will consist of 30Gy in 10 equal fractions. The RT schedule will be 5 initial fractions, then a 4-12 week break and then the final 5 fractions. Each group of 5 treatments must be delivered within a 7 day period.

Locations (1)

Greenwich Hospital

Greenwich, Connecticut, United States